cmd condition onset (.xlsx)
===========================

:download:`Download original .xlsx file from GitHub <https://github.com/UCL/TLOmodel/raw/master/resources/cmd/ResourceFile_cmd_condition_onset.xlsx>`

.. contents::

info
----

====  ============================================================================================================================================================================================================================
  ..  ResourceFile\_cmd\_condition\_onset
====  ============================================================================================================================================================================================================================
   0  Created by Britta Jewell on 25 March 2021
   1
   2  This file reads in parameters for the onset of each condition annually in the CMD module in the TLO model. Each tab represents one condition modelled.
   3  baseline\_annual\_probability has been calibrated for each condition to data from Malawi. All other parameters are from Professor Ed Gregg's group. Where possible, sources are listed to the right of the parameter values.
====  ============================================================================================================================================================================================================================

diabetes
--------

====  =====================================================  ==================  =======================================
  ..  parameter\_name                                        value               Unnamed: 2
====  =====================================================  ==================  =======================================
   0  baseline\_annual\_probability                          0.00028
   1  rr\_male                                               1.15                Holden et al., 2013, UK Pop (CPRD)
   2  rr\_0\_4                                               0                   Holden et al., 2013, UK Pop (CPRD)
   3  rr\_5\_9                                               0                   Holden et al., 2013, UK Pop (CPRD)
   4  rr\_10\_14                                             0                   Holden et al., 2013, UK Pop (CPRD)
   5  rr\_15\_19                                             0                   Holden et al., 2013, UK Pop (CPRD)
   6  rr\_20\_24                                             1                   Holden et al., 2013, UK Pop (CPRD)
   7  rr\_25\_29                                             1                   Holden et al., 2013, UK Pop (CPRD)
   8  rr\_30\_34                                             1.6                 Holden et al., 2013, UK Pop (CPRD)
   9  rr\_35\_39                                             2.215384615384615   Holden et al., 2013, UK Pop (CPRD)
  10  rr\_40\_44                                             3                   Holden et al., 2013, UK Pop (CPRD)
  11  rr\_45\_49                                             4                   Holden et al., 2013, UK Pop (CPRD)
  12  rr\_50\_54                                             4.5                 Holden et al., 2013, UK Pop (CPRD)
  13  rr\_55\_59                                             6                   Holden et al., 2013, UK Pop (CPRD)
  14  rr\_60\_64                                             6.5                 Holden et al., 2013, UK Pop (CPRD)
  15  rr\_65\_69                                             7                   Holden et al., 2013, UK Pop (CPRD)
  16  rr\_70\_74                                             4                   Holden et al., 2013, UK Pop (CPRD)
  17  rr\_75\_79                                             3                   Holden et al., 2013, UK Pop (CPRD)
  18  rr\_80\_84                                             2                   Holden et al., 2013, UK Pop (CPRD)
  19  rr\_85\_89                                             2                   Holden et al., 2013, UK Pop (CPRD)
  20  rr\_90\_94                                             1                   Holden et al., 2013, UK Pop (CPRD)
  21  rr\_95\_99                                             1                   Holden et al., 2013, UK Pop (CPRD)
  22  rr\_100                                                1                   Holden et al., 2013, UK Pop (CPRD)
  23  rr\_urban
  24  rr\_wealth\_1                                          1                   Bellou et al., Systematic Reviews, 2018
  25  rr\_wealth\_2                                          0.8333333333333334  Bellou et al., Systematic Reviews, 2018
  26  rr\_wealth\_3                                          0.7916666666666666  Bellou et al., Systematic Reviews, 2018
  27  rr\_wealth\_4                                          0.75                Bellou et al., Systematic Reviews, 2018
  28  rr\_wealth\_5                                          0.7083333333333334  Bellou et al., Systematic Reviews, 2018
  29  rr\_bmi\_1                                             1.1                 Bellou et al., Systematic Reviews, 2018
  30  rr\_bmi\_2                                             1                   Bellou et al., Systematic Reviews, 2018
  31  rr\_bmi\_3                                             2.9                 Bellou et al., Systematic Reviews, 2018
  32  rr\_bmi\_4                                             6                   Bellou et al., Systematic Reviews, 2018
  33  rr\_bmi\_5                                             10                  Bellou et al., Systematic Reviews, 2018
  34  rr\_low\_exercise                                      1.33                Bellou et al., Systematic Reviews, 2018
  35  rr\_high\_salt                                         1
  36  rr\_high\_sugar                                        1.2                 Bellou et al., Systematic Reviews, 2018
  37  rr\_tobacco                                            1.3                 Bellou et al., Systematic Reviews, 2018
  38  rr\_alcohol
  39  rr\_marital\_status\_1
  40  rr\_marital\_status\_2
  41  rr\_marital\_status\_3
  42  rr\_in\_education                                      1.2                 Bellou et al., Systematic Reviews, 2018
  43  rr\_current\_education\_level\_1                       1.2                 Bellou et al., Systematic Reviews, 2018
  44  rr\_current\_education\_level\_2                       1                   Bellou et al., Systematic Reviews, 2018
  45  rr\_current\_education\_level\_3                       0.85                Bellou et al., Systematic Reviews, 2018
  46  rr\_unimproved\_sanitation                             1
  47  rr\_no\_access\_handwashing                            1
  48  rr\_no\_clean\_drinking\_water                         1.05                Estimates from Ed Gregg
  49  rr\_wood\_burning\_stove                               1.05                Estimates from Ed Gregg
  50  rr\_diabetes                                           1
  51  rr\_hypertension                                       1.75                Bellou et al., Systematic Reviews, 2018
  52  rr\_depression                                         1.48                Bellou et al., Systematic Reviews, 2018
  53  rr\_chronic\_kidney\_disease                           1
  54  rr\_chronic\_lower\_back\_pain                         1
  55  rr\_chronic\_ischemic\_heart\_disease                  1
  56  rr\_cancers                                            1
  57  rr\_ever\_stroke                                       1
  58  rr\_ever\_heart\_attack                                1
  59  rr\_diabetes\_on\_medication                           1
  60  rr\_hypertension\_on\_medication                       1
  61  rr\_chronic\_kidney\_disease\_on\_medication           1
  62  rr\_chronic\_lower\_back\_pain\_on\_medication         1
  63  rr\_chronic\_ischemic\_heart\_disease\_on\_medication  1
  64  rr\_stroke\_on\_medication                             1
  65  rr\_heart\_attack\_on\_medication                      1
====  =====================================================  ==================  =======================================

hypertension
------------

====  =====================================================  ===================  ===========================================================
  ..  parameter\_name                                        value                Unnamed: 2
====  =====================================================  ===================  ===========================================================
   0  baseline\_annual\_probability                          0.0045
   1  rr\_male                                               0.95
   2  rr\_0\_4                                               0                    Health Survey for England Hypertension Prevalence Models
   3  rr\_5\_9                                               0                    Health Survey for England Hypertension Prevalence Models
   4  rr\_10\_14                                             0                    Health Survey for England Hypertension Prevalence Models
   5  rr\_15\_19                                             0                    Health Survey for England Hypertension Prevalence Models
   6  rr\_20\_24                                             0.33783783783783783  Health Survey for England Hypertension Prevalence Models
   7  rr\_25\_29                                             1.0033783783783785   Health Survey for England Hypertension Prevalence Models
   8  rr\_30\_34                                             1.0033783783783785   Health Survey for England Hypertension Prevalence Models
   9  rr\_35\_39                                             1                    Health Survey for England Hypertension Prevalence Models
  10  rr\_40\_44                                             1                    Health Survey for England Hypertension Prevalence Models
  11  rr\_45\_49                                             1.652027027027027    Health Survey for England Hypertension Prevalence Models
  12  rr\_50\_54                                             1.652027027027027    Health Survey for England Hypertension Prevalence Models
  13  rr\_55\_59                                             2.135135135135135    Health Survey for England Hypertension Prevalence Models
  14  rr\_60\_64                                             2.135135135135135    Health Survey for England Hypertension Prevalence Models
  15  rr\_65\_69                                             2.385135135135135    Health Survey for England Hypertension Prevalence Models
  16  rr\_70\_74                                             2.385135135135135    Health Survey for England Hypertension Prevalence Models
  17  rr\_75\_79                                             2.679054054054054    Health Survey for England Hypertension Prevalence Models
  18  rr\_80\_84                                             2.679054054054054    Health Survey for England Hypertension Prevalence Models
  19  rr\_85\_89                                             2.679054054054054    Health Survey for England Hypertension Prevalence Models
  20  rr\_90\_94                                             2.679054054054054    Health Survey for England Hypertension Prevalence Models
  21  rr\_95\_99                                             2.679054054054054    Health Survey for England Hypertension Prevalence Models
  22  rr\_100                                                2.679054054054054    Health Survey for England Hypertension Prevalence Models
  23  rr\_urban
  24  rr\_wealth\_1                                          1                    Coyle et al., 2019, English GP Data
  25  rr\_wealth\_2                                          1.0396039603960396   Coyle et al., 2019, English GP Data
  26  rr\_wealth\_3                                          1.0693069306930694   Coyle et al., 2019, English GP Data
  27  rr\_wealth\_4                                          1.0396039603960396   Coyle et al., 2019, English GP Data
  28  rr\_wealth\_5                                          0.9900990099009901   Coyle et al., 2019, English GP Data
  29  rr\_bmi\_1                                             0.5263157894736842   Health Survey for England Hypertension Prevalence Models
  30  rr\_bmi\_2                                             1                    Health Survey for England Hypertension Prevalence Models
  31  rr\_bmi\_3                                             1.6894736842105265   Health Survey for England Hypertension Prevalence Models
  32  rr\_bmi\_4                                             1.7210526315789474   Health Survey for England Hypertension Prevalence Models
  33  rr\_bmi\_5                                             2.2052631578947373   Health Survey for England Hypertension Prevalence Models
  34  rr\_low\_exercise                                      1.16                 Andriolo et al., 2019, EPIC-Potsdam Study
  35  rr\_high\_salt                                         1.88                 Chen et al., 2018, Taiwan, Genetic Study
  36  rr\_high\_sugar                                        1.03                 Estimate from Ed Greg
  37  rr\_tobacco                                            1.04                 Andriolo et al., 2019, EPIC-Potsdam Study
  38  rr\_alcohol                                            1.31                 Pajak et al., 2013, HAPIEE Study, Russia Poland Czech
  39  rr\_marital\_status\_1                                 1                    Estimate from Ed Greg
  40  rr\_marital\_status\_2                                 1.449                Estimate from Ed Greg
  41  rr\_marital\_status\_3                                 1.03                 Estimate from Ed Greg
  42  rr\_in\_education                                      1
  43  rr\_current\_education\_level\_1                       1.34                 Health Survey for England Hypertension Prevalence Models
  44  rr\_current\_education\_level\_2                       1                    Health Survey for England Hypertension Prevalence Models
  45  rr\_current\_education\_level\_3                       1.42                 Health Survey for England Hypertension Prevalence Models
  46  rr\_unimproved\_sanitation                             1
  47  rr\_no\_access\_handwashing                            1
  48  rr\_no\_clean\_drinking\_water                         1
  49  rr\_wood\_burning\_stove                               1
  50  rr\_diabetes                                           1.92                 Derakhshan et al., 2016, Iranian Study
  51  rr\_hypertension                                       1
  52  rr\_depression                                         1.42                 Lin et al., 2012, Meta-Analysis Depression and Hypertension
  53  rr\_chronic\_kidney\_disease                           1
  54  rr\_chronic\_lower\_back\_pain                         1
  55  rr\_chronic\_ischemic\_heart\_disease                  1
  56  rr\_cancers                                            1
  57  rr\_ever\_stroke                                       1
  58  rr\_ever\_heart\_attack                                1
  59  rr\_diabetes\_on\_medication                           1
  60  rr\_hypertension\_on\_medication                       1
  61  rr\_chronic\_kidney\_disease\_on\_medication           1
  62  rr\_chronic\_lower\_back\_pain\_on\_medication         1
  63  rr\_chronic\_ischemic\_heart\_disease\_on\_medication  1
  64  rr\_stroke\_on\_medication                             1
  65  rr\_heart\_attack\_on\_medication                      1
====  =====================================================  ===================  ===========================================================

chronic_lower_back_pain
-----------------------

====  =====================================================  ==================  ================================================================
  ..  parameter\_name                                        value               Unnamed: 2
====  =====================================================  ==================  ================================================================
   0  baseline\_annual\_probability                          0.006
   1  rr\_male                                               1
   2  rr\_0\_4                                               0
   3  rr\_5\_9                                               0
   4  rr\_10\_14                                             0
   5  rr\_15\_19                                             0
   6  rr\_20\_24                                             0.69
   7  rr\_25\_29                                             1
   8  rr\_30\_34                                             1.4461538461538461
   9  rr\_35\_39                                             2.215384615384615
  10  rr\_40\_44                                             2.769230769230769
  11  rr\_45\_49                                             3.538461538461538
  12  rr\_50\_54                                             3.815384615384615
  13  rr\_55\_59                                             5
  14  rr\_60\_64                                             4.923076923076923
  15  rr\_65\_69                                             4.369230769230769
  16  rr\_70\_74                                             4.369230769230769
  17  rr\_75\_79                                             4.923076923076923
  18  rr\_80\_84                                             4.369230769230769
  19  rr\_85\_89                                             3.692307692307692
  20  rr\_90\_94                                             1.6153846153846154
  21  rr\_95\_99                                             1.5384615384615383
  22  rr\_100                                                1.5384615384615383
  23  rr\_urban
  24  rr\_wealth\_1                                          1                   Docking et al, 2011; Cambridge City over 75s Cohort
  25  rr\_wealth\_2                                          0.9                 Docking et al, 2011; Cambridge City over 75s Cohort
  26  rr\_wealth\_3                                          1                   Docking et al, 2011; Cambridge City over 75s Cohort
  27  rr\_wealth\_4                                          1.4                 Docking et al, 2011; Cambridge City over 75s Cohort
  28  rr\_wealth\_5                                          1.4                 Docking et al, 2011; Cambridge City over 75s Cohort
  29  rr\_bmi\_1                                             1                   Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study
  30  rr\_bmi\_2                                             1                   Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study
  31  rr\_bmi\_3                                             1.21                Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study
  32  rr\_bmi\_4                                             1.28                Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study
  33  rr\_bmi\_5                                             1.28                Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study
  34  rr\_low\_exercise
  35  rr\_high\_salt
  36  rr\_high\_sugar
  37  rr\_tobacco                                            1.78                Shiri et al., 2010; meta-analysis
  38  rr\_alcohol
  39  rr\_marital\_status\_1                                 1                   Docking et al, 2011; Cambridge City over 75s Cohort
  40  rr\_marital\_status\_2                                 1.4285714285714286  Docking et al, 2011; Cambridge City over 75s Cohort
  41  rr\_marital\_status\_3                                 1.5714285714285716  Docking et al, 2011; Cambridge City over 75s Cohort
  42  rr\_in\_education                                      1.5                 Docking et al, 2011; Cambridge City over 75s Cohort
  43  rr\_current\_education\_level\_1                       1.5                 Docking et al, 2011; Cambridge City over 75s Cohort
  44  rr\_current\_education\_level\_2                       1                   Docking et al, 2011; Cambridge City over 75s Cohort
  45  rr\_current\_education\_level\_3                       1                   Docking et al, 2011; Cambridge City over 75s Cohort
  46  rr\_unimproved\_sanitation
  47  rr\_no\_access\_handwashing
  48  rr\_no\_clean\_drinking\_water
  49  rr\_wood\_burning\_stove
  50  rr\_diabetes                                           2.72                Pozzobbon et al, 2019, meta-analysis
  51  rr\_hypertension                                       0.79                Bae et al, 2015, KNHANES IV
  52  rr\_depression                                         1.5                 Docking et al, 2011; Cambridge City over 75s Cohort
  53  rr\_chronic\_kidney\_disease
  54  rr\_chronic\_lower\_back\_pain
  55  rr\_chronic\_ischemic\_heart\_disease
  56  rr\_cancers
  57  rr\_ever\_stroke                                       2.35                Wang et al, 2020
  58  rr\_ever\_heart\_attack                                1
  59  rr\_diabetes\_on\_medication                           1
  60  rr\_hypertension\_on\_medication                       1
  61  rr\_chronic\_kidney\_disease\_on\_medication           1
  62  rr\_chronic\_lower\_back\_pain\_on\_medication         1
  63  rr\_chronic\_ischemic\_heart\_disease\_on\_medication  1
  64  rr\_stroke\_on\_medication                             1
  65  rr\_heart\_attack\_on\_medication                      1
====  =====================================================  ==================  ================================================================

chronic_kidney_disease
----------------------

====  =====================================================  ==================  ===========================================
  ..  parameter\_name                                        value               Unnamed: 2
====  =====================================================  ==================  ===========================================
   0  baseline\_annual\_probability                          0.0007
   1  rr\_male                                               1.25                Judge A. et al. Nep Dial Trans. 2012
   2  rr\_0\_4                                               0
   3  rr\_5\_9                                               0
   4  rr\_10\_14                                             0
   5  rr\_15\_19                                             0
   6  rr\_20\_24                                             0.5154639175257733  Judge A. et al. Nep Dial Trans. 2012
   7  rr\_25\_29                                             0.5154639175257733  Judge A. et al. Nep Dial Trans. 2012
   8  rr\_30\_34                                             0.5154639175257733  Judge A. et al. Nep Dial Trans. 2012
   9  rr\_35\_39                                             1                   Judge A. et al. Nep Dial Trans. 2012
  10  rr\_40\_44                                             1                   Judge A. et al. Nep Dial Trans. 2012
  11  rr\_45\_49                                             1.675257731958763   Judge A. et al. Nep Dial Trans. 2012
  12  rr\_50\_54                                             1.675257731958763   Judge A. et al. Nep Dial Trans. 2012
  13  rr\_55\_59                                             2.8762886597938144  Judge A. et al. Nep Dial Trans. 2012
  14  rr\_60\_64                                             2.8762886597938144  Judge A. et al. Nep Dial Trans. 2012
  15  rr\_65\_69                                             4.190721649484536   Judge A. et al. Nep Dial Trans. 2012
  16  rr\_70\_74                                             4.190721649484536   Judge A. et al. Nep Dial Trans. 2012
  17  rr\_75\_79                                             5.190721649484536   Judge A. et al. Nep Dial Trans. 2012
  18  rr\_80\_84                                             5.190721649484536   Judge A. et al. Nep Dial Trans. 2012
  19  rr\_85\_89                                             2.0876288659793816  Judge A. et al. Nep Dial Trans. 2012
  20  rr\_90\_94                                             2.0876288659793816  Judge A. et al. Nep Dial Trans. 2012
  21  rr\_95\_99                                             2.0876288659793816  Judge A. et al. Nep Dial Trans. 2012
  22  rr\_100                                                2.0876288659793816  Judge A. et al. Nep Dial Trans. 2012
  23  rr\_urban
  24  rr\_wealth\_1                                          1                   Weldegiorgis M. et al. Nep Dial Trans. 2020
  25  rr\_wealth\_2                                          1.26                Weldegiorgis M. et al. Nep Dial Trans. 2020
  26  rr\_wealth\_3                                          1.36                Weldegiorgis M. et al. Nep Dial Trans. 2020
  27  rr\_wealth\_4                                          1.63                Weldegiorgis M. et al. Nep Dial Trans. 2020
  28  rr\_wealth\_5                                          1.73                Weldegiorgis M. et al. Nep Dial Trans. 2020
  29  rr\_bmi\_1                                             1.02                Herrington WG. et al. PLoS One. 2017
  30  rr\_bmi\_2                                             1                   Herrington WG. et al. PLoS One. 2018
  31  rr\_bmi\_3                                             1.45                Herrington WG. et al. PLoS One. 2019
  32  rr\_bmi\_4                                             1.66                Herrington WG. et al. PLoS One. 2020
  33  rr\_bmi\_5                                             2.2                 Herrington WG. et al. PLoS One. 2021
  34  rr\_low\_exercise
  35  rr\_high\_salt
  36  rr\_high\_sugar
  37  rr\_tobacco                                            1.24                Bello A et al. Clin J Am Soc Nephrol. 2008
  38  rr\_alcohol                                            1.33                Hossain M et al. Nephron Clin Pract. 2012
  39  rr\_marital\_status\_1                                 1                   Akrawi D et al. Eur J Intern Med. 2014
  40  rr\_marital\_status\_2                                 0.8620689655172414  Akrawi D et al. Eur J Intern Med. 2014
  41  rr\_marital\_status\_3                                 0.8620689655172414  Akrawi D et al. Eur J Intern Med. 2014
  42  rr\_in\_education                                      1.3454545454545452  Weldegiorgis M. et al. Nep Dial Trans. 2020
  43  rr\_current\_education\_level\_1                       1.1818181818181817  Fored C et al. Nep Dial Tran. 2003
  44  rr\_current\_education\_level\_2                       1                   Fored C et al. Nep Dial Tran. 2003
  45  rr\_current\_education\_level\_3                       0.9090909090909091  Fored C et al. Nep Dial Tran. 2003
  46  rr\_unimproved\_sanitation
  47  rr\_no\_access\_handwashing
  48  rr\_no\_clean\_drinking\_water
  49  rr\_wood\_burning\_stove
  50  rr\_diabetes                                           1.87                Bello A et al. Clin J Am Soc Nephrol. 2008
  51  rr\_hypertension                                       1.75                Bello A et al. Clin J Am Soc Nephrol. 2008
  52  rr\_depression                                         1.62                Kop W et al. Clin J Am Soc Nephrol. 2011
  53  rr\_chronic\_kidney\_disease                           1
  54  rr\_chronic\_lower\_back\_pain                         1.3                 Lipworth et al. PlosOne 2012
  55  rr\_chronic\_ischemic\_heart\_disease                  1
  56  rr\_cancers                                            1
  57  rr\_ever\_stroke                                       1
  58  rr\_ever\_heart\_attack                                1
  59  rr\_diabetes\_on\_medication                           1
  60  rr\_hypertension\_on\_medication                       1
  61  rr\_chronic\_kidney\_disease\_on\_medication           1
  62  rr\_chronic\_lower\_back\_pain\_on\_medication         1
  63  rr\_chronic\_ischemic\_heart\_disease\_on\_medication  1
  64  rr\_stroke\_on\_medication                             1
  65  rr\_heart\_attack\_on\_medication                      1
====  =====================================================  ==================  ===========================================

chronic_ischemic_hd
-------------------

====  =====================================================  ==================  ====================================================================================================================================================================================================================================================
  ..  parameter\_name                                        value               Unnamed: 2
====  =====================================================  ==================  ====================================================================================================================================================================================================================================================
   0  baseline\_annual\_probability                          8.6e-05
   1  rr\_male                                               2.3
   2  rr\_0\_4                                               0
   3  rr\_5\_9                                               0
   4  rr\_10\_14                                             0
   5  rr\_15\_19                                             0
   6  rr\_20\_24                                             0.1401360544217687  IHME https://vizhub.healthdata.org/gbd-compare/
   7  rr\_25\_29                                             1                   IHME https://vizhub.healthdata.org/gbd-compare/
   8  rr\_30\_34                                             1                   IHME https://vizhub.healthdata.org/gbd-compare/
   9  rr\_35\_39                                             1                   IHME https://vizhub.healthdata.org/gbd-compare/
  10  rr\_40\_44                                             1                   IHME https://vizhub.healthdata.org/gbd-compare/
  11  rr\_45\_49                                             1                   IHME https://vizhub.healthdata.org/gbd-compare/
  12  rr\_50\_54                                             7                   IHME https://vizhub.healthdata.org/gbd-compare/
  13  rr\_55\_59                                             7                   IHME https://vizhub.healthdata.org/gbd-compare/
  14  rr\_60\_64                                             7                   IHME https://vizhub.healthdata.org/gbd-compare/
  15  rr\_65\_69                                             7                   IHME https://vizhub.healthdata.org/gbd-compare/
  16  rr\_70\_74                                             12                  IHME https://vizhub.healthdata.org/gbd-compare/
  17  rr\_75\_79                                             12                  IHME https://vizhub.healthdata.org/gbd-compare/
  18  rr\_80\_84                                             12                  IHME https://vizhub.healthdata.org/gbd-compare/
  19  rr\_85\_89                                             12                  IHME https://vizhub.healthdata.org/gbd-compare/
  20  rr\_90\_94                                             12                  IHME https://vizhub.healthdata.org/gbd-compare/
  21  rr\_95\_99                                             12                  IHME https://vizhub.healthdata.org/gbd-compare/
  22  rr\_100                                                12                  IHME https://vizhub.healthdata.org/gbd-compare/
  23  rr\_urban
  24  rr\_wealth\_1                                          1                   Witte et al., 2017, Deprivation Chronic Heart Failure, UK
  25  rr\_wealth\_2                                          1.12                Witte et al., 2017, Deprivation Chronic Heart Failure, UK
  26  rr\_wealth\_3                                          1.24                Witte et al., 2017, Deprivation Chronic Heart Failure, UK
  27  rr\_wealth\_4                                          1.36                Witte et al., 2017, Deprivation Chronic Heart Failure, UK
  28  rr\_wealth\_5                                          1.48                Witte et al., 2017, Deprivation Chronic Heart Failure, UK
  29  rr\_bmi\_1                                             1                   Jousilahti et al, 1996, BMI CVD Finland
  30  rr\_bmi\_2                                             1                   Jousilahti et al, 1996, BMI CVD Finland
  31  rr\_bmi\_3                                             2.08                Jousilahti et al, 1996, BMI CVD Finland
  32  rr\_bmi\_4                                             7.28                Jousilahti et al, 1996, BMI CVD Finland
  33  rr\_bmi\_5                                             12.48               Jousilahti et al, 1996, BMI CVD Finland
  34  rr\_low\_exercise                                      2.4                 Strazzullo et al, 2009, Meta-analysis
  35  rr\_high\_salt                                         1.17                Strazzullo et al, 2009, Meta-analysis
  36  rr\_high\_sugar
  37  rr\_tobacco                                            1.4                 Strazzullo et al, 2009, Meta-analysis
  38  rr\_alcohol                                            1.44                Emberson et al., 2005 Alcohol CHD
  39  rr\_marital\_status\_1
  40  rr\_marital\_status\_2
  41  rr\_marital\_status\_3
  42  rr\_in\_education                                      1.67                Kilander et al, 2001, Swedish Cohort Men
  43  rr\_current\_education\_level\_1                       1.67                Kilander et al, 2001, Swedish Cohort Men
  44  rr\_current\_education\_level\_2                       1
  45  rr\_current\_education\_level\_3                       1
  46  rr\_unimproved\_sanitation
  47  rr\_no\_access\_handwashing
  48  rr\_no\_clean\_drinking\_water
  49  rr\_wood\_burning\_stove
  50  rr\_diabetes                                           2.19                Asia Pacific Cohort Studies Collaboration, 2003
  51  rr\_hypertension                                       3.8                 Alderman et al, 1997, MI HTN
  52  rr\_depression
  53  rr\_chronic\_kidney\_disease                           1.55                Angelantonio et al., 2010, Prospective Study Iceland
  54  rr\_chronic\_lower\_back\_pain
  55  rr\_chronic\_ischemic\_heart\_disease
  56  rr\_cancers
  57  rr\_ever\_stroke                                       1
  58  rr\_ever\_heart\_attack                                1
  59  rr\_diabetes\_on\_medication                           1
  60  rr\_hypertension\_on\_medication                       0.72                Neal et al., Effects of ACE inhibitors, calcium antagonists, and other blood- pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration, The Lancet 2000
  61  rr\_chronic\_kidney\_disease\_on\_medication           1
  62  rr\_chronic\_lower\_back\_pain\_on\_medication         1
  63  rr\_chronic\_ischemic\_heart\_disease\_on\_medication  1
  64  rr\_stroke\_on\_medication                             1
  65  rr\_heart\_attack\_on\_medication                      1
====  =====================================================  ==================  ====================================================================================================================================================================================================================================================

